A

Artrya Ltd
ASX:AYA

Watchlist Manager
Artrya Ltd
ASX:AYA
Watchlist
Price: 3.93 AUD 4.24% Market Closed
Market Cap: 621.3m AUD

Artrya Ltd
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Artrya Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Artrya Ltd
ASX:AYA
Total Current Liabilities
AU$2.1m
CAGR 3-Years
0%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Total Current Liabilities
AU$14.4m
CAGR 3-Years
12%
CAGR 5-Years
17%
CAGR 10-Years
38%
4DMedical Ltd
ASX:4DX
Total Current Liabilities
AU$19.3m
CAGR 3-Years
26%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Total Current Liabilities
$13.3m
CAGR 3-Years
-10%
CAGR 5-Years
0%
CAGR 10-Years
17%
Pro Medicus Ltd
ASX:PME
Total Current Liabilities
AU$43.1m
CAGR 3-Years
17%
CAGR 5-Years
28%
CAGR 10-Years
25%
Alcidion Group Ltd
ASX:ALC
Total Current Liabilities
AU$20.9m
CAGR 3-Years
-5%
CAGR 5-Years
17%
CAGR 10-Years
115%
No Stocks Found

Artrya Ltd
Glance View

Market Cap
621.3m AUD
Industry
Health Care

Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). The company is headquartered in Perth, Western Australia. The company went IPO on 2021-11-26. The firm is focused on operating diagnostic imaging center. The company is primarily engaged in providing powered image-analysis software for coronary artery disease. Its non-invasive solution, Salix uses artificial intelligence (AI) to produce a 3D image and report that provides an accurate detection of coronary artery disease, including the presence of vulnerable plaque. Salix offers precision medicine for cardiac care. The company enables clinicians to triage patients and identify individuals at high risk of heart attack. The firm's cardiac-health report provides diagnostic support to radiologists and cardiologists.

AYA Intrinsic Value
2.65 AUD
Overvaluation 33%
Intrinsic Value
Price
A

See Also

What is Artrya Ltd's Total Current Liabilities?
Total Current Liabilities
2.1m AUD

Based on the financial report for Jun 30, 2025, Artrya Ltd's Total Current Liabilities amounts to 2.1m AUD.

What is Artrya Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
67%

Over the last year, the Total Current Liabilities growth was 32%.

Back to Top